Care Access Research
Care Access is a global research company dedicated to accelerating the arrival of new medicines by establishing a network of research sites, supporting community screenings, and providing staffing solutions. They focus on making clinical trials more accessible, inclusive, and efficient, with a mission to improve health outcomes and increase representation in clinical research.
Industries
Nr. of Employees
large (251-1000)
Care Access Research
Products
Alzheimer's
A comprehensive community health screening and direct-access laboratory testing service that screens for pTau protein levels to assess Alzheimer's risk, alongside cardiovascular and metabolic health markers.
Alzheimer’s Disease Research Study
Clinical research study aiming to help prevent or slow down early symptoms of Alzheimer's disease.
pTau Blood Test
A direct-access blood test that screens for levels of the pTau protein to help assess the risk of developing Alzheimer's disease.
Preventive Health Screening and Clinical Research Services
Comprehensive community-based health screening and direct-access laboratory testing in partnership with Walmart, assessing risks for Alzheimer's disease, heart disease, liver disease, and more.
Future of Medicine Health Screening
A comprehensive community health screening program offering an investigational pTau blood test for early Alzheimer's risk assessment alongside routine preventive cardiovascular and metabolic lab testing including Lp(a), A1C, and a lipid panel.
Clinical Research Sites and Site Support Services
A global network of sites and principal investigators providing a wide range of research services, mobile capabilities, and centralized support.
Alzheimer's
A comprehensive community health screening and direct-access laboratory testing service that screens for pTau protein levels to assess Alzheimer's risk, alongside cardiovascular and metabolic health markers.
Alzheimer’s Disease Research Study
Clinical research study aiming to help prevent or slow down early symptoms of Alzheimer's disease.
pTau Blood Test
A direct-access blood test that screens for levels of the pTau protein to help assess the risk of developing Alzheimer's disease.
Preventive Health Screening and Clinical Research Services
Comprehensive community-based health screening and direct-access laboratory testing in partnership with Walmart, assessing risks for Alzheimer's disease, heart disease, liver disease, and more.
Future of Medicine Health Screening
A comprehensive community health screening program offering an investigational pTau blood test for early Alzheimer's risk assessment alongside routine preventive cardiovascular and metabolic lab testing including Lp(a), A1C, and a lipid panel.
Clinical Research Sites and Site Support Services
A global network of sites and principal investigators providing a wide range of research services, mobile capabilities, and centralized support.
Services
Large-scale community screening events and pre-screening workflows that provide health screening tests and identify potential trial participants in local settings.
Scalable staff augmentation including on-site, traveling, and virtual clinical research personnel and centralized remote support functions.
Deployment of mobile research clinics and temporary physical space to conduct study visits and enable participation in locations without permanent research infrastructure.
Management and coordination of a distributed network of clinical research sites with centralized quality oversight to support multi-site and multi-country studies.
Programs that provide patient education, advocacy, and navigation to reduce non-medical barriers and support participant retention throughout trials.
Large-scale community screening events and pre-screening workflows that provide health screening tests and identify potential trial participants in local settings.
Scalable staff augmentation including on-site, traveling, and virtual clinical research personnel and centralized remote support functions.
Deployment of mobile research clinics and temporary physical space to conduct study visits and enable participation in locations without permanent research infrastructure.
Management and coordination of a distributed network of clinical research sites with centralized quality oversight to support multi-site and multi-country studies.
Programs that provide patient education, advocacy, and navigation to reduce non-medical barriers and support participant retention throughout trials.
Expertise Areas
- Decentralized clinical trial operations
- Community-based participant recruitment
- Site staffing and clinical operations support
- Biomarker screening and clinical laboratory testing
Key Technologies
- Decentralized clinical trial methods
- Mobile clinic/mobile research vehicles
- Central laboratory and biomarker assays
- Participant pre-screening web platforms
News & Updates
Adults with ulcerative colitis in Ogden, Utah, may join a clinical trial assessing an investigational oral medication for long-term remission.
A new research site in Sun City Center, Florida, will evaluate an investigational treatment to prevent or slow Alzheimer’s disease.
Care Access supports AstraZeneca’s trial for AZD7442, using decentralized, mobile research sites to reach communities with limited access.
Studies in Baltimore, Dorchester, and Lima are evaluating a new investigational treatment for elevated Lp(a), a risk factor for cardiovascular disease.
Care Access is conducting studies to evaluate treatments for elevated Lp(a), a genetic risk factor for heart attack and stroke, in various US locations.
Adults with ulcerative colitis in Ogden, Utah, may join a clinical trial assessing an investigational oral medication for long-term remission.
A new research site in Sun City Center, Florida, will evaluate an investigational treatment to prevent or slow Alzheimer’s disease.
Care Access supports AstraZeneca’s trial for AZD7442, using decentralized, mobile research sites to reach communities with limited access.
Studies in Baltimore, Dorchester, and Lima are evaluating a new investigational treatment for elevated Lp(a), a risk factor for cardiovascular disease.
Care Access is conducting studies to evaluate treatments for elevated Lp(a), a genetic risk factor for heart attack and stroke, in various US locations.